US Market News
4月前
Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement DeviceMarch 10, 2026 10:45 AM
PR Newswire (US)
The PR agency was tapped for its deep healthcare communications expertise and will introduce the ThermAffyx™ Patient Safety System. STAMFORD, Conn., March 10, 2026 /PRNewswire/ -- Gentherm, the global market leader of innovative thermal management and pneumatic comfort technologies, and KNB Communications, an award-winning healthcare marketing and public relations agency, figuratively shook hands today when they jointly announced a partnership between the two companies.
As the official agency of record for Gentherm's medical division, KNB Communications will leverage its expertise in strategic communications and media relations to support the launch of Gentherm's innovative ThermAffyx™ Patient Safety System, a first-of-its-kind medical device designed to solve both the patient warming and patient securement challenge during surgery in a single, integrated solution. "ThermAffyx is a solution born of clinical need," explained Gentherm's Steve Fletcher, SVP & General Manager, Medical. "Surgeons identified Gentherm as a company that could design a product to improve patient safety. We recognized the impact of that story and chose KNB Communications for its ability to create and share compelling narratives."Chintan Shah, President of KNB Communications, expressed his enthusiasm about the collaboration and noted its perfectly aligned with the agency's expertise in the medical device space. "At KNB Communications, we seek to partner with industry leaders announcing medical breakthroughs — from promising clinical trials to transformative technologies that improve patient safety. Our role is to translate complex science into clear, credible stories that help clinicians, investors, and patients understand why these innovations matter and how they shape the future of healthcare. ThermAffyx is the latest example, and we're proud to bring more awareness to Gentherm's market solutions," he said.Gentherm submitted a 510(k) Class II premarket notification to the FDA for the ThermAffyx™ Patient Safety System earlier this year. FDA clearance is expected in May.About Gentherm: Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2024, the company recorded annual sales of approximately $1.5 billion and secured $2.4 billion in automotive new business awards. For more information, go to www.gentherm.com.About KNB Communications: Headquartered in Stamford, Connecticut, KNB Communications is an award-winning public relations and marketing agency specializing in the healthcare AI, life sciences, medical devices, and dental and health technology domains. The medical marketing and PR firm is widely recognized for developing creative, strategic, and impactful integrated campaigns. The KNB team is made up of media relations, social media, email marketing, content, website, digital marketing, and video experts. Media contact: Amy Roberts
aroberts@knbcomm.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/gentherm-medical-selects-knb-communications-to-amplify-news-of-its-groundbreaking-patient-warming-and-securement-device-302709655.htmlSOURCE KNB Communications LLC
Original: Gentherm Medical Selects KNB Communications to Amplify News of its Groundbreaking Patient Warming and Securement Device
whytestocks
7年前
News: $THRM Gentherm to Participate in the J.P. Morgan Auto Conference
NORTHVILLE, Mich., July 26, 2019 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader and developer of innovative thermal management technologies, today announced that Phil Eyler, President and CEO, and Matteo Anversa, Executive Vice President, CFO and Treasurer, will partic...
Find out more Gentherm to Participate in the J.P. Morgan Auto Conference
surf1944
18年前
Skin aesthetic company Thermage to buy Reliant Technologies for $95M
Thermage Inc. will acquire Reliant Technologies Inc. in a stock and cash transaction valued at approximately $95 million, the companies said Monday.
Hayward-based Thermage (NASDAQ: THRM) focuses on non-invasive skin tightening; Mountain View-based Reliant Technologies is a privately held company that focuses on skin resurfacing through its Fraxel line of products.
The companies said the deal would "combine market leaders in skin tightening and skin resurfacing, the two fastest growing segments of the industry."
Thermage and Reliant generated nearly $137 million in revenue on a combined basis for the 12 months ended March 31.
"The transaction is expected to create cross selling opportunities in the domestic and international markets," the companies said, adding that annual cost savings from the combination are expected to be approximately $14 million.
The boards of both companies have approved the proposed transaction, which is subject to customary closing conditions, including approval by the stockholders of Thermage.
The stockholders of Reliant have already approved the transaction by written consent.
"This proposed combination brings together two companies with premier technologies and market positions in their respective fields and creates a company with significantly more potential than either company can realize on its own," said Eric Stang, president and CEO of Reliant Technologies. "Through this combination, Thermage and Reliant Technologies are leading the way toward industry consolidation and establishing a stronger company capable of continued industry leadership."
Reliant Technologies generated approximately $72.5 million in revenue during the 12 months ended March 31.
surf1944
18年前
Photos: Thermage Presents New Guidelines To Enhance Liposuction Results
Wednesday June 25, 8:00 am ET
Thermage is the recommended solution for post liposuction skin tightening
HAYWARD, Calif., June 25 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News) announced the introduction of recommended procedure guidelines for physicians when performing Thermage in combination with liposuction. Thermage promotes improved results and helps to minimize common side effects from liposuction when used in combination with liposuction procedures.
To view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/thermage/33777/
"Uneven surface and skin laxity after liposuction are very common, especially in patients of certain age or if the patient's weight changes," said Dr. Alex De Souza, a Plastic Surgeon with offices in Charleston, West Virginia. "I use Thermage as the best non-invasive treatment available to correct these minor imperfections and obtain smoother results which translates to happier patients."
The American Society of Plastic Surgeons (ASPS)*, the American Society for Aesthetic Plastic Surgery (ASAPS)** and the International Society of Aesthetic Plastic Surgeons (ISAPS) mention asymmetry, rippling of the skin, bumps, uneven surfaces and loose skin as the most common unwanted results of liposuction.
When the Thermage procedure is performed after a liposuction surgery it can help reduce these surgical side effects with proven skin tightening and deep contouring of the body. Thermage can further improve the results of liposuction, increasing patient satisfaction with the overall outcome.
"Several of our clinicians have been using Thermage for post-liposuction skin tightening and body shaping for some time now," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "The results they are seeing are remarkable and, in the opinion of these doctors, Thermage offers an excellent solution for the correction of unwanted results of liposuction."
These new guidelines will be presented for the first time during a webinar by Dr. Alex De Souza on June 25th, 2008 at 5:00pm PDT. For details and to register go to http://www.thermage.com/physicians/events.cfm.
Thermage has been safely used on over 500,000 patients worldwide to stimulate existing collagen and promote new collagen growth. Patients benefit from a single treatment and results can be subtle to dramatic depending on the individual patient. All Thermage procedures use a unique, patented monopolar capacitive radiofrequency technology for volumetric heating of the tissue that is backed by years of clinical research and has been featured in over 45 peer-reviewed scientific articles.
surf1944
18年前
Thermage Announces First Quarter 2008 Financial Results
Thursday May 8, 4:01 pm ET
Systems and Tip Revenue Up Domestically and Internationally
U.S. Sales Increase 8% Year-Over-Year
U.S. ThermaCool NXT System Sales Grow 29% Year-Over-Year
HAYWARD, Calif., May 8 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News), a leader in non-invasive tissue tightening in the aesthetic industry, reported today its financial results for the first quarter ended March 31, 2008.
Revenue for the first quarter of 2008 was $16.2 million, up 7% from $15.2 million for the first quarter of 2007. Domestic revenue increased 8% and international revenue was up 6% compared with the prior year's first quarter. Gross profit for the first quarter of 2008 was $11.9 million, representing 73.2% of revenue, compared with $11.0 million, or 72.6% of revenue, for the same quarter of 2007.
The Company reported a net loss of $2.2 million, or $(0.09) per share, versus net income of $0.1 million, or breakeven earnings per share, for the same quarter of the prior year. Non-GAAP (1) net loss for the first quarter of 2008 was $1.3 million, or $(0.05) per share, compared to net income of $1.3 million, or $0.05 per diluted share, for the prior year period. Included in the first quarter 2008 net loss were approximately $1.0 million of expenses for business development activities that were terminated during the quarter.
"We grew revenue both in the U.S. and internationally, despite a softening aesthetics market," said Stephen J. Fanning, Chairman, President and Chief Executive Officer. "Revenue from both treatment tips and systems increased during the quarter. Our systems sales during the quarter included a high percentage of upgrades for existing customers, the second highest quarter for upgrade units since the NXT system was introduced in the first quarter of 2007. The growth in upgrades demonstrates the continued commitment by our customers to Thermage procedures."
"Thermage is focused on a strategy that includes organic growth, as well as complementary acquisitions that add value for our customers and shareholders," continued Mr. Fanning. "One of the primary reasons behind our IPO was to raise funds that would allow us to pursue this strategy. During the first quarter, we reached an advanced stage of negotiations with a potential acquisition target and had performed significant due diligence on the project before negotiations were terminated. We incurred approximately $1.0 million in outside advisory fees pursuing this acquisition. We remain committed to our strategy to build our presence in the aesthetics market, both organically and through acquisitions that will allow us to expand our product offerings to our customer base and leverage our operating infrastructure."
"Looking at the remainder of 2008, the recent bifurcation of our domestic salesforce, innovative sales strategies such as our Infinity program, and recently introduced tips and procedures, we believe we are positioned for continued revenue growth. While we anticipate that economic conditions will remain challenging throughout the year, we will continue our focus to drive revenue, expand market share, and build upon our reputation as a leader in safe, effective skin tightening and contouring procedures," concluded Mr. Fanning.
Guidance:
Management currently expects 2008 revenue to be in a range of $67 million to $70 million. With the revised revenue guidance, as well as the business development expenses incurred during the first quarter, the Company expects net income for the full year 2008 on a GAAP basis to be between breakeven and $0.03 per diluted share. Non-GAAP (1) net income for the full year 2008, which excludes estimated stock based compensation charges of approximately $4.6 million, is expected to be in a range of $0.18 to $0.21 per diluted share. The per share earnings amounts are based on weighted average shares of 26 million.
Non-GAAP Presentation:
(1) To supplement the condensed financial information presented on a GAAP
basis, management has provided non-GAAP net income and loss, and
non-GAAP earnings per share measures that exclude the impact of all
stock-based compensation expenses, net of income taxes. The Company
believes that these non-GAAP financial measures provide investors with
insight into what is used by management to conduct a more meaningful
and consistent comparison of the Company's ongoing operating results
and trends, compared with historical results. This presentation is
also consistent with management's internal use of the measure, which
it uses to measure the performance of ongoing operating results,
against prior periods and against our internally developed targets. A
table reconciling the GAAP financial measures to the non-GAAP measures
is included in the condensed financial information attached to this
release.
Conference Call
The conference call is scheduled to begin at 1:30 p.m. PDT (4:30 p.m. EDT) on May 8, 2008. The call will be broadcast live over the Internet hosted at the Investor Relations section of the Company's website at http://www.thermage.com. In addition, you may call to listen to the live broadcast: 866-249-5225 for domestic participants and 303-262-2006 for international participants. Participating in the call will be Stephen J. Fanning, Chairman, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer.
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain accessible for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers. Both callers will need to use the Passcode 11113200#. An archived webcast will also be available at http://www.thermage.com.
surf1944
18年前
Thermage Announces Technological Advances Featured at ASLMS Meeting
Thursday April 3, 8:00 am ET
KISSIMMEE, Fla., April 3, 2008 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News) today announced that physician investigators will be presenting clinical research using Thermage technology during the 28th Annual Conference for the American Society for Laser Medicine & Surgery (ASLMS), from both the podium and during a Thermage organized symposium featuring leading experts in the field.
Topics covered during the meeting include advances in skin tightening technology, clinical outcomes using the deep contouring tip for Body Shape procedures and the new treatment for cellulite. Additionally research will be presented on how Thermage technology may be applied for future applications such as fat reduction.
Thermage technology will be featured in the following sessions:
-- Anne C. Chapas, M.D., Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.
-- Robert A. Weiss, M.D. Skin Rejuvenation Session April 3rd
8 a.m. - 12 p.m.
-- Christopher Zachary, M.D. "Effects of Monopolar Radiofrequency on the
subcutaneous fat layer in an animal model", Cutaneous Laser Surgery
Session April 6th 8.55 a.m.
Clinical studies accepted as poster presentations include:
-- Sofia Rubbani, M.D. "Advances in Monopolar Radiofrequency for the
treatment of stretch marks in the arms, thighs and abdomens"
-- Neil Saddick, M.D "Immediate effect of a new monopolar radiofrequency
treatment tip on cellulite"
The Thermage Symposium will be held on Thursday April 3rd at 7pm at the Gaylord Palms Resort, Osceola B. The symposium will be moderated by Jeffrey Dover, M.D and will feature Robert Weiss, M.D, Karyn Grossman, M.D and Suzanne Bruce, M.D. The symposium will cover how continual innovation has maintained Thermage technology as the gold standard in skin tightening and contouring for face and body. There will also be a discussion on how Thermage technology and these new applications can be integrated into an aesthetic practice.
"Thermage is dedicated to continual innovation to expand our platform with new applications and to drive the efficacy and value of our products to meet the needs of our customers," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "The clinical findings being presented at ASLMS are a testament to our commitment to commercialize products that are based on thorough scientific and clinical research as well as our long-standing partnerships with pre-eminent researchers and practitioners in the field."
Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Singhania
3年前
ernie44
6年前
stocktrademan
12年前
メールアドレスで登録
